Tuberculosis Elimination Camp and Healthy Liver Mission

• 22 May 2025

Why in News? 

 The Governor of Madhya Pradesh honoured stakeholders of the 100-day Ni-Kshay Shivir Abhiyan and launched the state-wide Healthy Liver Mission in Bhopal. 

 Key Points 

100-Day Ni-Kshay Shivir Abhiyan 

• Under the National Tuberculosis Elimination Program, the state conducted special health camps to identify TB cases, ensure timely treatment, and raise public awareness about the disease. 
  • The campaign enabled citizens to receive testing and consultations through the joint efforts of the health department, NGOs, public representatives, and civil society. 
• Under this campaign, over 5,000 Gram Panchayats have been declared TB-free.  
  • Seoni and Betul districts have secured the highest number of TB-free Gram Panchayats for three consecutive years. 
  • Kanhar (Mandla), Patwa (Balaghat), and Sawarwani (Chhindwara) have achieved TB-free status. 
• The state government is striving for 100% coverage under the initiative, aiming to eliminate TB from the state by 2028. 

 Healthy Liver Mission 

• This initiative is aimed at combating liver-related diseases. 
  • India leads the world in fatty liver disease prevention, with Madhya Pradesh emerging as the top-performing state in the country. 
• The mission will focus on awareness, early detection, treatment, and prevention of conditions such as hepatitis B and C, fatty liver, and cirrhosis. 
• Under this, the health department will conduct screening camps, provide medical training, offer consultations, and distribute free medicines statewide. 

 National TB Elimination Programme (NTEP)  

• In 2020, the Revised National Tuberculosis Control Program (RNTCP) was renamed the NTEP with the goal to eliminate TB in India by 2025, five years ahead of the global target of 2030.   
• The program is guided by the National Strategic Plan (2017-2025) under the strategic pillars: Detect – Treat – Prevent – Build (DTPB).  
• The NTEP focuses on early diagnosis, quality-assured treatment, engaging private providers, contact tracing in high-risk areas, and addressing social determinants through a multi-sectoral approach.  
• The programme recorded its highest-ever case notifications, reporting 25.5 lakh TB cases in 2023 and 26.07 lakh cases in 2024.  
• Under NTEP, India introduced improved drug-resistant TB treatments, including a safer, shorter all-oral Bedaquiline regimen, increasing success rates from 68% in 2020 to 75% in 2022.   
  • The mBPaL regimen (Bedaquiline, Pretomanid, Linezolid) offers 80% success for MDR-TB, reducing treatment duration to six months. 

 Fatty Liver Disease 

• Fatty liver disease (hepatic steatosis) is the buildup of excess fat in liver cells. 
  • It becomes unhealthy when fat exceeds 5% of liver cells (hepatocytes), affecting liver function and metabolism. 
• It is of 2 types- NAFLD (Non-Alcoholic Fatty Liver Disease) & Alcoholic Fatty Liver Disease (AFLD)